BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 126 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5,795,223 | +19.1% | 53,769 | +4.8% | 0.01% | +25.0% |
Q1 2024 | $4,867,077 | +24.1% | 51,308 | +20.7% | 0.00% | +33.3% |
Q4 2023 | $3,920,754 | +37.5% | 42,506 | -25.1% | 0.00% | 0.0% |
Q3 2023 | $2,850,838 | -20.0% | 56,767 | +0.6% | 0.00% | 0.0% |
Q2 2023 | $3,564,543 | +83.5% | 56,401 | +30.6% | 0.00% | +50.0% |
Q1 2023 | $1,942,488 | +12.4% | 43,176 | +9.5% | 0.00% | 0.0% |
Q4 2022 | $1,727,866 | -6.2% | 39,440 | +41.0% | 0.00% | 0.0% |
Q3 2022 | $1,842,000 | +130.0% | 27,963 | +179.6% | 0.00% | +100.0% |
Q4 2019 | $801,000 | -51.5% | 10,000 | -55.6% | 0.00% | -50.0% |
Q3 2019 | $1,653,000 | -38.7% | 22,500 | -21.3% | 0.00% | -33.3% |
Q2 2019 | $2,698,000 | +68.5% | 28,600 | +43.0% | 0.00% | +50.0% |
Q1 2019 | $1,601,000 | +79.9% | 20,000 | +106.0% | 0.00% | +100.0% |
Q1 2018 | $890,000 | +18.0% | 9,711 | -2.9% | 0.00% | 0.0% |
Q4 2017 | $754,000 | +14.4% | 10,000 | -39.3% | 0.00% | 0.0% |
Q1 2017 | $659,000 | +121.1% | 16,479 | +55.2% | 0.00% | – |
Q4 2016 | $298,000 | – | 10,618 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |